BNPMDA: Bipartite Network Projection for MiRNA–Disease Association prediction
暂无分享,去创建一个
Lei Wang | Qi Zhao | Zhu-Hong You | Xing Chen | Di Xie | Hongsheng Liu | Xing Chen | Zhuhong You | Qi Zhao | Hongsheng Liu | Lei Wang | Di Xie
[1] Bernhard Puppe,et al. MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype. , 2011, Blood.
[2] Qionghai Dai,et al. WBSMDA: Within and Between Score for MiRNA-Disease Association prediction , 2016, Scientific Reports.
[3] Qionghai Dai,et al. RBMMMDA: predicting multiple types of disease-microRNA associations , 2015, Scientific Reports.
[4] M. von Brandenstein,et al. MicroRNA 15a, inversely correlated to PKCα, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples. , 2012, The American journal of pathology.
[5] P. Sarnow,et al. Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.
[6] A. Pasquinelli,et al. A sense-able microRNA , 2016, Genes & development.
[7] Ujjwal Maulik,et al. Development of the human cancer microRNA network , 2010 .
[8] Q. Cui,et al. An Analysis of Human MicroRNA and Disease Associations , 2008, PloS one.
[9] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[10] Fang Zhou,et al. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. , 2008, Cancer research.
[11] Yi-Cheng Zhang,et al. Bipartite network projection and personal recommendation. , 2007, Physical review. E, Statistical, nonlinear, and soft matter physics.
[12] Frank J. Slack,et al. The Role of MicroRNAs in Cancer , 2006, The Yale journal of biology and medicine.
[13] Xi Chen,et al. Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls. , 2012, Carcinogenesis.
[14] Yi Wang,et al. Circulating miR-155 Expression in Plasma: A Potential Biomarker for Early Diagnosis of Esophageal Cancer in Humans , 2012, Journal of toxicology and environmental health. Part A.
[15] V. Ambros,et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.
[16] Xing Chen,et al. Semi-supervised learning for potential human microRNA-disease associations inference , 2014, Scientific Reports.
[17] P. Leedman,et al. Regulation of Epidermal Growth Factor Receptor Signaling and Erlotinib Sensitivity in Head and Neck Cancer Cells by miR-7 , 2012, PloS one.
[18] Yadong Wang,et al. Prioritization of disease microRNAs through a human phenome-microRNAome network , 2010, BMC Systems Biology.
[19] Xia Li,et al. Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes , 2013, BMC Systems Biology.
[20] J. H. Ward. Hierarchical Grouping to Optimize an Objective Function , 1963 .
[21] Xing Chen,et al. HGIMDA: Heterogeneous graph inference for miRNA-disease association prediction , 2016, Oncotarget.
[22] Shangwei Ning,et al. Prioritizing human cancer microRNAs based on genes’ functional consistency between microRNA and cancer , 2011, Nucleic acids research.
[23] P. Enzinger,et al. Esophageal cancer. , 2003, The New England journal of medicine.
[24] Aliasgar Moiyadi,et al. Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway. , 2010, Journal of cancer research and therapeutics.
[25] Zhu-Hong You,et al. A novel approach based on KATZ measure to predict associations of human microbiota with non‐infectious diseases , 2016, Bioinform..
[26] S. Manfredi. Le cancer du côlon : du dépistage de masse au traitement personnalisé , 2014, Oncologie.
[27] Dong Wang,et al. Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases , 2010, Bioinform..
[28] Yun Xiao,et al. Prioritizing Candidate Disease miRNAs by Topological Features in the miRNA Target–Dysregulated Network: Case Study of Prostate Cancer , 2011, Molecular Cancer Therapeutics.
[29] Siu-Ming Yiu,et al. Predicting drug-target interaction for new drugs using enhanced similarity measures and super-target clustering1 , 2014, 2014 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).
[30] Yun Xiao,et al. Prioritizing candidate disease miRNAs by integrating phenotype associations of multiple diseases with matched miRNA and mRNA expression profiles. , 2014, Molecular bioSystems.
[31] Alberto Izzotti,et al. MicroRNAs: Modulators of Cell Identity, and their Applications in Tissue Engineering , 2014, MicroRNA.
[32] F. Sarkar,et al. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells. , 2012, Carcinogenesis.
[33] Jian-Yu Shi,et al. Predicting drug-target interaction for new drugs using enhanced similarity measures and super-target clustering. , 2015, Methods.
[34] Xing Chen,et al. RWRMDA: predicting novel human microRNA-disease associations. , 2012, Molecular bioSystems.
[35] J. Sun,et al. miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer , 2012, British Journal of Cancer.
[36] Zhu-Hong You,et al. Detection of Interactions between Proteins through Rotation Forest and Local Phase Quantization Descriptors , 2015, International journal of molecular sciences.
[37] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[38] Jan Gorodkin,et al. Protein-driven inference of miRNA–disease associations , 2013, Bioinform..
[39] Yukio Kitade,et al. Downregulation of microRNAs‐143 and ‐145 in B‐cell malignancies , 2007, Cancer science.
[40] Yang Li,et al. HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..
[41] Yufei Huang,et al. Prediction of microRNAs Associated with Human Diseases Based on Weighted k Most Similar Neighbors , 2013, PloS one.
[42] G. Ruvkun,et al. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans , 1993, Cell.
[43] Wanqing Chen,et al. Esophageal cancer statistics in China, 2011: Estimates based on 177 cancer registries , 2015, Thoracic cancer.
[44] Sandro Banfi,et al. microRNAs and genetic diseases , 2009, PathoGenetics.
[45] M K Schwartz,et al. Enzymes in colon cancer. General information , 1975 .